Warrant Exercise AND PREFERRED STOCK AMENDMENT AGREEMENTWarrant Exercise and Preferred Stock Amendment Agreement • March 26th, 2020 • Jaguar Health, Inc. • Pharmaceutical preparations
Contract Type FiledMarch 26th, 2020 Company IndustryThis Warrant Exercise and Preferred Stock Amendment Agreement (this “Agreement”), dated as of March 24, 2020, is between Jaguar Health, Inc. (the “Company”) and the purchaser signatory thereto (the “Purchaser”). Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Certificate of Designation of Preferences, Rights and Limitations of Series B Convertible Preferred Stock (the “Series B Certificate of Designation”) and the Series 2 Warrants (as defined below).